Health Canada this week announced significant revisions to its national cannabis industry regulations, including changes to rules that govern licensing, production, packaging and labelling, security, and record keeping, according to analysis by StratCann. The new rules, published Wednesday in the federal government’s Canada Gazette, are aimed at addressing industry concerns …
The U.S. Food and Drug Administration last week sent a warning letter to a California manufacturer that has been marketing an injectable hemp CBD product to medical patients. The letter, dated March 6, was sent to Sacramento-based Pico IV and asserts that its “intravenous form of cannabidiol” is an “unapproved …
SNDL Inc. (NASDAQ: SNDL) said in regulatory filings that it picked up 5.4% of High Tide’s shares on March 10. The company disclosed the purchase in a Schedule 13G form that reported SNDL acquired 4.35 million shares of the Canadian retailer. The transaction was first reported by StratCann. While neither …
The department’s cannabis cultivation regulatory package is designed to streamline administration and strengthen consumer protection. …
The cannabis company’s new retail facility in the Columbus area will donate its opening profits to Homes for Families. …
The UN Commission on Narcotic Drugs approved a recommendation to include the cannabinoid in the 1971 Convention on Psychotropic Substances. …
Executives with The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) during the company’s quarterly earnings call said they’re about halfway through a “turnaround” plan to make the company profitable, but didn’t mention the financial filing this week which reported a $205 million net loss for the business last… …
California-based WM Technology Inc. (Nasdaq: MAPS), the parent company of popular online dispensary finder Weedmaps, reported net income of $12.2 million for the 2024 calendar year, a reversal from 2023, when it lost $15.7 million. The profitable year was also a huge turnaround from two years ago, when Weedmaps lost… …
While delta-8-THC and delta-9-THC were the most frequently identified synthetically derived cannabinoids, investigators also identified highly potent novel cannabinoids such as THCP and HHC in nearly one-third to one-half of products. The post Analysis: Most […]
Respondents were most likely to report using cannabis to manage pain or mobility (81 percent), sleep (62 percent), PTSD or anxiety (43 percent), stress (43 percent), and depression (29 percent). The post Survey: Nearly Half […]
If enacted next year, no future initiatives pertaining to how marijuana or other controlled substances are regulated will be permitted to appear on the Idaho ballot. The post Idaho: Voters May No Longer Be Able […]
Under current law, state-registered patients may possess either herbal cannabis or infused tinctures, capsules, or topical patches. The post North Dakota: Lawmakers Advance Competing Bills Permitting Edible Forms of Medical Cannabis appeared first on NORML.
Toronto-based Neural Therapeutics (CSE: NURL) announced on Thursday a twofold milestone, with both the completion of a C$518,500 capital raise and the receipt of formal permission from the Canadian Securities Exchange to begin listing its shares for trading, another sign that the international psychedelics industry is making slow but steady… …
The strategic partnership increases consumer availability for premium cannabis beverages. …
The cannabis company also reported its second full year of positive cash from operations and positive free cash flow. …
The cannabis company continues to complete divestitures, reduce operating and overhead costs, and refine its inventory assortment. …
The bipartisan legislation to legalize medical cannabis aims to set up a system of importation that collides with federal law. …
Illinois-based Cresco Labs (CSE: CL) (OTCQX: CRLBF) isn’t rushing to open recreational retail cannabis sales in New York anytime soon, but is “excited” about its entrance into Kentucky’s medical marijuana scene this coming year, company leadership said during the quarterly earnings call Wednesday. CEO Charlie Bachtell repeatedly referred to the …
The legislation could further the argument that cannabis has currently accepted medical use despite federal prohibition in the U.S. …
UC Asset LP (OTCQB: UCASU) bought a $3 million cannabis property, which includes 1,550 square feet of office space and 16,500 square feet of cannabis cultivation space. UC Asset told investors that it previously owned 50% of the property, which it acquired in May 2023, paying $1 million cash and issuing $600,000 of preferred… …